The U.S. Food and Drug Administration on Wednesday approved Sanofi SA's dengue vaccine Dengvaxia for use in the United States among people aged 9 through 16 who have laboratory-confirmed previous dengue infection and live in endemic areas. (https://b...
Original Article: Sanofi wins FDA approval to sell dengue shot in parts of U.S.